Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
about
Cardiovascular risk in rheumatoid arthritis: assessment, management and next stepsThe inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachLong QT Syndrome: An Emerging Role for Inflammation and ImmunityHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsCardiovascular comorbidity in rheumatic diseases: a focus on heart failureMy treatment approach to rheumatoid arthritisCardiorheumatology: cardiac involvement in systemic rheumatic diseaseManaging cardiovascular risk in patients with inflammatory arthritis: practical considerationsTargeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic DrugsPrevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategiesCardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases.Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.Statin use and mortality in rheumatoid arthritis: a general population-based cohort studyKnowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis.Association between autoimmune rheumatic diseases and the risk of dementiaImaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation.Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.Why do people with rheumatoid arthritis still die prematurely?Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.Do rheumatoid arthritis patients have a higher risk for sleep apnea?Mortality trends in rheumatoid arthritis: the role of rheumatoid factorCardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.Autoantibodies and the risk of cardiovascular events.Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Expanded network of inflammatory markers of atherogenesis: where are we now?Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisAssociation of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase InhibitorsCardiovascular morbidity and mortality in rheumatoid arthritis.Left ventricular function in treatment-naive early rheumatoid arthritis.Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study.Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigationTotal cholesterol and LDL levels decrease before rheumatoid arthritis.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentPatients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.The influence of early menopause on cardiovascular risk in women with rheumatoid arthritis.Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study.
P2860
Q26744334-B39B3294-D98B-4518-8D65-8F61633C5091Q26765937-9C74BA41-EC35-4D4F-9603-EB2082FA7B39Q26769710-7BD0DA74-3CDF-47DA-89BC-E3965ECAC2DBQ26774658-FD73E76A-DEFE-4F0A-872B-92EE963675F9Q26823443-21E1E1F8-B006-4815-A441-CF165463DAADQ26829955-714B77C3-FC31-476A-9588-FA9525199949Q27008927-1BB10676-2C23-4061-BF4A-6410109ACD50Q27694518-3AA6E1E6-E7E3-41C3-94DD-E986B7C1E543Q28073436-DCC39552-6416-411D-9A90-5D8CE4D3193FQ28200569-DBB5E16D-B2F5-4A3E-A781-88BD27EC152AQ30355778-5E62E1E5-511E-4DF7-9949-982A85991867Q31005025-D1B40363-ED1C-4F37-B456-5F5383AE1830Q33474334-C780982C-98A5-474A-B354-D53E0743BE79Q33482833-3F54AB18-51E0-4DFD-8051-582D456934B2Q33579891-140F470F-80FA-44C8-AF25-7981696624E2Q33588462-CC11A5EF-3A39-424F-976B-AB6FBFE7A816Q33596583-D6F9E0AE-E164-4640-A1AB-1FF7A1162539Q33615845-BEE1FABD-E4BC-49F0-A2B0-380B26EDD2C6Q33678290-9ECD366E-78B2-4AD9-9418-1BCC8F701B4CQ33687843-A7E0966C-B7E0-4569-B839-2B76EAC4B258Q33697879-E56E79BE-93CC-4757-A1AC-53F2B6000F72Q33709082-5F840894-66A7-4424-A0FF-09502F8440BEQ33709615-39DDCC7F-B8FE-450D-B2AA-0DAADE03E4AFQ33709660-75EADC84-DC3D-429A-AA82-C9B5EE16DA5FQ33713206-83886107-E94B-4989-8B30-AA004C45378BQ33721605-CE46EB58-0657-41DC-90AA-5BC2AEA270ACQ33725505-63253DF1-FDF5-4BD3-825B-8A27B01D8D69Q33738532-A7CDDCA9-DAA2-4E68-BC29-871352CF8672Q33740199-3D197E37-9027-476A-A6FD-F1EB8C236323Q33763342-CCC4AA66-205D-43A0-BF3D-C598379134EFQ33806651-608A9968-9484-4E43-8B5F-A43900B5D4FBQ33847043-E62013DF-CC3C-498C-B8B5-589E29D2336EQ33859039-32E081DA-F1A0-4A5C-8349-63A78E7D9DBCQ33890221-2CFDFC57-689A-45F0-8968-E5916192B1B2Q33931317-432767BC-58EA-4917-8265-6A71EEBC213CQ33943374-ED975CA6-87DB-4F68-B2A9-8E4E200FB2B1Q33951592-3A81B71E-3FFE-466E-9CCD-969FC99CF3CFQ33956849-A9E56B67-8C56-47D8-AF69-115329D3EDDEQ33973884-E71E7FF2-8302-435C-B084-50673C68499CQ34027546-98E4D07B-E36F-4704-8BC2-CFAC46FBB7AA
P2860
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increased unrecognized coronar ...... population-based cohort study.
@ast
Increased unrecognized coronar ...... population-based cohort study.
@en
type
label
Increased unrecognized coronar ...... population-based cohort study.
@ast
Increased unrecognized coronar ...... population-based cohort study.
@en
prefLabel
Increased unrecognized coronar ...... population-based cohort study.
@ast
Increased unrecognized coronar ...... population-based cohort study.
@en
P2093
P2860
P356
P1476
Increased unrecognized coronar ...... population-based cohort study
@en
P2093
Cynthia S Crowson
Hilal Maradit-Kremers
Paulo J Nicola
Sherine E Gabriel
Véronique L Roger
P2860
P304
P356
10.1002/ART.20853
P577
2005-02-01T00:00:00Z